Artificial Intelligence in Drug Discovery: Transforming Target Identification to Lead Optimization
International Journal of Drug Delivery Technology · 22.04.2026 · 16 (16s)
DOI: 10.25258/ijddt.16.16s.8 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 22.04.2026. Verfasst von Ranjan Banerjee und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Artificial intelligence (AI) is reshaping drug discovery by improving how teams prioritize biological hypotheses, triage chemical space, and optimize leads under multi-parameter constraints. Across the early pipeline—from target identification and validation to hit discovery and lead optimization—modern machine learning integrates human genetics, multi-omics, biomedical knowledge graphs, structure prediction, and molecular representation learning to support decision-making in iterative design–make–test–analyze (DMTA) cycles. At the same time, the field faces persistent barriers that determine real-world impact: biased and noisy labels, inflated retrospective benchmarks due to leakage and overly permissive data splits, limited prospective validation, and insufficient uncertainty calibration. This review synthesizes methods and best practices across the target-to-lead workflow, focusing on (i) data foundations and representations, (ii) AI for target discovery and evidence integration, (iii) structure-enabled screening and interaction modeling, and (iv) multi-objective, synthesis-aware lead optimization using predictive and generative models. We conclude with practical recommendations for building credible, auditable AI workflows aligned with emerging regulatory guidance and good AI practice principles.
Zitieren
APA
Banerjee, R., M, T., Raju, R. N., Ghosh, S., Das, J., Kaur, R., & S, K. R. J. (2026). Artificial Intelligence in Drug Discovery: Transforming Target Identification to Lead Optimization. International Journal of Drug Delivery Technology, 16(16s). https://doi.org/10.25258/ijddt.16.16s.8
Vancouver
Banerjee R, M T, Raju RN, Ghosh S, Das J, Kaur R, et al. Artificial Intelligence in Drug Discovery: Transforming Target Identification to Lead Optimization. International Journal of Drug Delivery Technology. 2026;16(16s). doi:10.25258/ijddt.16.16s.8
BibTeX
@article{Banerjee2026,
author = {Banerjee, Ranjan and M, Thangaraj and Raju, Rajath N and Ghosh, Subham and Das, Jisu and Kaur, Ramandeep and S, Krishna Raj J},
title = {Artificial Intelligence in Drug Discovery: Transforming Target Identification to Lead Optimization},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {16s},
doi = {10.25258/ijddt.16.16s.8}
}
EUVIMED